Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 2001, p. 3623-3624, Vol. 45, No. 12
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.12.3623-3624.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Antimicrobial Susceptibilities of Group B
Streptococci Isolated from Patients with Invasive Disease:
10-Year Perspective
David R.
Murdoch* and
L. Barth
Reller
Clinical Microbiology Laboratory, Duke
University Medical Center, Durham, North Carolina 27710
Received 1 June 2001/Returned for modification 3 July
2001/Accepted 5 September 2001
Antimicrobial susceptibility testing of 192 group B streptococcal
isolates from patients with invasive disease demonstrated that 31 (16%) were resistant to erythromycin and 17 (9%) were resistant to
clindamycin. One isolate demonstrated high-level resistance to
streptomycin, but none was highly resistant to gentamicin. Erythromycin
and clindamycin are no longer reliable empirical alternatives to
penicillin for the treatment and prevention of group B streptococcal infections.
*
Corresponding author. Present address: Microbiology
Unit, Canterbury Health Laboratories, P.O. Box 151, Christchurch, New Zealand. Phone: 64 3 364 0347. Fax: 64 3 364 0238. E-mail:
david.murdoch{at}cdhb.govt.nz.
Antimicrobial Agents and Chemotherapy, December 2001, p. 3623-3624, Vol. 45, No. 12
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.12.3623-3624.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nagano, N., Nagano, Y., Kimura, K., Tamai, K., Yanagisawa, H., Arakawa, Y.
(2008). Genetic Heterogeneity in pbp Genes among Clinically Isolated Group B Streptococci with Reduced Penicillin Susceptibility. Antimicrob. Agents Chemother.
52: 4258-4267
[Abstract]
[Full Text]
-
Richter, S. S., Howard, W. J., Weinstein, M. P., Bruckner, D. A., Hindler, J. F., Saubolle, M., Doern, G. V.
(2007). Multicenter Evaluation of the BD Phoenix Automated Microbiology System for Antimicrobial Susceptibility Testing of Streptococcus Species. J. Clin. Microbiol.
45: 2863-2871
[Abstract]
[Full Text]
-
Gygax, S. E., Schuyler, J. A., Kimmel, L. E., Trama, J. P., Mordechai, E., Adelson, M. E.
(2006). Erythromycin and clindamycin resistance in group B streptococcal clinical isolates.. Antimicrob. Agents Chemother.
50: 1875-1877
[Abstract]
[Full Text]
-
Zeng, X., Kong, F., Wang, H., Darbar, A., Gilbert, G. L.
(2006). Simultaneous Detection of Nine Antibiotic Resistance-Related Genes in Streptococcus agalactiae Using Multiplex PCR and Reverse Line Blot Hybridization Assay. Antimicrob. Agents Chemother.
50: 204-209
[Abstract]
[Full Text]
-
Wehbeh, W., Rojas-Diaz, R., Li, X., Mariano, N., Grenner, L., Segal-Maurer, S., Tommasulo, B., Drlica, K., Urban, C., Rahal, J. J.
(2005). Fluoroquinolone-Resistant Streptococcus agalactiae: Epidemiology and Mechanism of Resistance. Antimicrob. Agents Chemother.
49: 2495-2497
[Abstract]
[Full Text]
-
Desjardins, M., Delgaty, K. L., Ramotar, K., Seetaram, C., Toye, B.
(2004). Prevalence and Mechanisms of Erythromycin Resistance in Group A and Group B Streptococcus: Implications for Reporting Susceptibility Results. J. Clin. Microbiol.
42: 5620-5623
[Abstract]
[Full Text]
-
Tang, P., Ng, P., Lum, M., Skulnick, M., Small, G. W., Low, D. E., Sarabia, A., Mazzulli, T., Wong, K., Simor, A. E., Willey, B. M.
(2004). Use of the Vitek-1 and Vitek-2 Systems for Detection of Constitutive and Inducible Macrolide Resistance in Group B Streptococci. J. Clin. Microbiol.
42: 2282-2284
[Abstract]
[Full Text]
-
Acikgoz, Z. C., Almayanlar, E., Gamberzade, S., Gocer, S.
(2004). Macrolide Resistance Determinants of Invasive and Noninvasive Group B Streptococci in a Turkish Hospital. Antimicrob. Agents Chemother.
48: 1410-1412
[Abstract]
[Full Text]
-
Heelan, J. S., Hasenbein, M. E., McAdam, A. J.
(2004). Resistance of Group B Streptococcus to Selected Antibiotics, Including Erythromycin and Clindamycin. J. Clin. Microbiol.
42: 1263-1264
[Abstract]
[Full Text]
-
Kawamura, Y., Fujiwara, H., Mishima, N., Tanaka, Y., Tanimoto, A., Ikawa, S., Itoh, Y., Ezaki, T.
(2003). First Streptococcus agalactiae Isolates Highly Resistant to Quinolones, with Point Mutations in gyrA and parC. Antimicrob. Agents Chemother.
47: 3605-3609
[Abstract]
[Full Text]
-
Lopardo, H. A., Vidal, P., Jeric, P., Centron, D., Paganini, H., Facklam, R. R., Elliott, J.
(2003). Six-Month Multicenter Study on Invasive Infections Due to Group B Streptococci in Argentina. J. Clin. Microbiol.
41: 4688-4694
[Abstract]
[Full Text]
-
Werno, A. M., Anderson, T. P., Murdoch, D. R.
(2003). Antimicrobial Susceptibilities of Group B Streptococci in New Zealand. Antimicrob. Agents Chemother.
47: 2710-2711
[Full Text]
-
Baker, C J, Edwards, M S
(2003). Group B streptococcal conjugate vaccines. Arch. Dis. Child.
88: 375-378
[Abstract]
[Full Text]
-
Betriu, C., Culebras, E., Gomez, M., Rodriguez-Avial, I., Sanchez, B. A., Agreda, M. C., Picazo, J. J.
(2003). Erythromycin and Clindamycin Resistance and Telithromycin Susceptibility in Streptococcus agalactiae. Antimicrob. Agents Chemother.
47: 1112-1114
[Abstract]
[Full Text]